US Stock Market Sector Analysis – Friday, July 24, 2026 MIXED

A coalition of major technology companies, venture firms and CEOs is pressing Washington to support open-weight AI models as essential to U.S. competitiveness, innovation and national security. Signatories include Microsoft’s Satya Nadella and NVIDIA’s Jensen Huang, and the letter argues that downloadable, transparent model weights enable broader experimentation and competition. The push comes as concerns grow about Chinese open-weight models — including allegations of unauthorized distillation of U.S. models — and recent security incidents have highlighted risks around model provenance and platform defenses. Market participants note the debate pits innovation and cost-efficiency against national-security and intellectual-property risks, and observers are watching how policymakers respond.

Intel (INTC) posts a stronger-than-expected revenue outlook driven by accelerating demand from AI data centers, yet the stock is volatile as investors weigh how much of a recovery is already priced in. Shares fell roughly 3% after earlier gains, while analysts at New Street Research say even a successful turnaround leaves structural cost disadvantages versus TSMC and ongoing share-pressure from ARM-based and NVIDIA designs. Management highlights improving yields and capacity that left unmet demand last quarter, but foundry margins remain negative and Intel plans disciplined capex of roughly $20 billion-plus over coming years with deployment tied to clear returns. Investors are watching execution on yields, gross margins and whether non-CPU AI product lines can scale beyond a currently modest run rate.

Clinical-stage gene-editing company Scribe Therapeutics, co-founded by Nobel laureate Jennifer Doudna, prices its IPO at $15 and is indicated to open markedly higher as the offering raises capital to advance a Phase 1 program. Scribe is developing epigenetic-editing therapies that alter protein production without permanently changing DNA, a distinction the company and its scientific backers say could ease regulatory and safety concerns compared with permanent genome edits. Management says proceeds will accelerate clinical development for a single-treatment approach aimed at lowering LDL cholesterol and other indications, positioning the technology as a potential alternative to chronic daily therapies. Market reaction to the IPO reflects renewed investor appetite for differentiated biotech platforms amid a cautious broader IPO climate.

A string of industry deals and strategic shifts underscores the speed and capital intensity of the AI and space cycles. AMD is teaming with Cerebras Systems on a co-designed server for low-latency inference, with Cerebras saying a disaggregated, standards-based architecture can deliver faster, more productive token generation; Cerebras shares are volatile around the announcement. BlackRock is marketing about $12.3 billion of high-grade bonds to finance a Meta data-center project, testing investor appetite as concerns grow about oversized AI infrastructure spending. In aerospace, SpaceX is preparing another Starship test flight even as it reportedly begins turning away some Falcon 9 customers beyond 2028 to reallocate resources for next‑generation launches. Separately, the EU escalates a probe of TikTok over youth privacy and safety issues, and regulators are increasingly scrutinizing AI technology in consumer-facing platforms.

U.S. markets finish the week mixed as investors digest a flurry of macro policy moves, elevated Treasury yields and rotating sector flows. The Dow trades higher while the Nasdaq faces pressure, leaving the S&P 500 roughly flat for the day and modestly negative for the week. The 30‑year Treasury yield sits around 5.16%, close to multi‑decade highs, keeping rate risk top of mind for equity investors heading into next week’s Fed meeting and September policy signaling.

Big‑cap tech stumbles weigh on benchmarks as several of the Mag 7 see heavy losses after a week of earnings and profit‑quality concerns. Tesla (TSLA) plunges after results that disappointed on profitability and produced negative free cash flow, while Alphabet (GOOGL), Meta (META), Amazon (AMZN) and Microsoft (MSFT) trade lower amid worries about cash flow, margins and next‑week earnings. Apple (AAPL) stands out as a relative bright spot, moving toward record highs as investors favor companies with lighter capex profiles. NVIDIA (NVDA) and some chip names buck the decline as semiconductor capital expenditure beneficiaries.

The semiconductor complex shows clear bifurcation and technical stress. The Philadelphia Semiconductor Index is back below the 12,000 head‑and‑shoulders level after intraday weakness, and memory and equipment names like Western Digital (WDC), Micron (MU) and Seagate (STX) post mixed results with gains for suppliers receiving AI capex orders and sharp losses for memory and certain equipment stocks. Analysts warn that failure to trigger a short‑covering rebound leaves downside risk toward lower support levels into next week.

Policy headlines also drive market activity. The administration implements new tariffs—broad 10% and 12.5% rates tied to a forced‑labor probe—that cover more than 80 countries and carry wide exemptions; effective tariff rates fall short of prior levels but underscore potential inflationary input costs for corporates. Market participants expect the tariff program and rising yields to influence Fed calculus, but Fed messaging ahead of the upcoming meeting is likely to remain measured, with little explicit guidance on an immediate rate hike according to prevailing market commentary. Corporate earnings headlines are plentiful next week, with Amazon (AMZN), Meta (META) and other large names scheduled to report and likely to set the tone for early August trading.